CC
Checkpoint Capital Portfolio holdings
AUM
$215M
This Quarter Return
-1.4%
1 Year Return
+27.24%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
(+11%)
Cap. Flow
+$18.1M
Cap. Flow
% of AUM
10.9%
Top 10 Holdings %
Top 10 Hldgs %
95.06%
Holding
21
New
4
Increased
8
Reduced
3
Closed
5
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$12.7M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$6.14M |
| 3 |
Phathom Pharmaceuticals
PHAT
|
$4.43M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$3.97M |
| 5 |
Protagonist Therapeutics
PTGX
|
$2.59M |
Top Sells
| 1 |
Mirum Pharmaceuticals
MIRM
|
$9.1M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$5.39M |
| 3 |
Verastem
VSTM
|
$1.99M |
| 4 |
GH Research
GHRS
|
$1.98M |
| 5 |
Corcept Therapeutics
CORT
|
$943K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Rhythm Pharmaceuticals
RYTM
$6.85B
| $37.9M | 22.82% |
922,100
+96,600
| +12% | +$3.97M |
|
2
argenx
ARGX
$43.6B
| $35.3M | 21.3% |
82,150
+150
| +0.2% | +$64.5K |
|
|
3
Axsome Therapeutics
AXSM
$6.05B
| $23.4M | 14.11% |
290,772
+158,335
| +120% | +$12.7M |
|
|
AVDL
4
Avadel Pharmaceuticals
AVDL
$1.43B
| $16M | 9.65% |
1,138,178
+436,791
| +62% | +$6.14M |
|
|
5
Protagonist Therapeutics
PTGX
$3.67B
| $12.3M | 7.42% |
355,000
+74,699
| +27% | +$2.59M |
|
6
Cytokinetics
CYTK
$4.23B
| $10.3M | 6.21% |
190,000
| – | – |
|
|
7
Phathom Pharmaceuticals
PHAT
$864M
| $9.01M | 5.43% |
875,000
+429,839
| +97% | +$4.43M |
|
|
8
Corcept Therapeutics
CORT
$7.35B
| $7.95M | 4.79% |
244,750
-29,026
| -11% | -$943K |
|
|
ATYR
9
aTyr Pharma
ATYR
$527M
| $3.04M | 1.83% |
1,946,477
+500,000
| +35% | +$780K |
|
10
Pliant Therapeutics
PLRX
$101M
| $2.5M | 1.5% |
+232,200
| New | +$2.5M |
|
11
Kymera Therapeutics
KYMR
$2.95B
| $2.45M | 1.48% |
+82,000
| New | +$2.45M |
|
12
Cidara Therapeutics
CDTX
$1.66B
| $1.74M | 1.05% |
+145,417
| New | +$1.74M |
|
13
Trevi Therapeutics
TRVI
$883M
| $1.49M | 0.9% |
500,089
-5,993
| -1% | -$17.9K |
|
14
Applied Therapeutics
APLT
$71M
| $1.06M | 0.64% |
227,470
+7,470
| +3% | +$34.9K |
|
15
Soleno Therapeutics
SLNO
$3.6B
| $804K | 0.48% |
+19,695
| New | +$804K |
|
|
ALLK
16
DELISTED
Allakos
ALLK
| $650K | 0.39% |
649,957
-118,007
| -15% | -$118K |
|
|
17
Ironwood Pharmaceuticals
IRWD
$214M
| – | – |
-618,528
| Closed | -$5.39M |
|
|
18
Mirum Pharmaceuticals
MIRM
$3.71B
| – | – |
-362,193
| Closed | -$9.1M |
|
|
19
Verastem
VSTM
$569M
| – | – |
-168,739
| Closed | -$1.99M |
|
20
Atara Biotherapeutics
ATRA
$84.6M
| – | – |
-892,853
| Closed | -$620K |
|
|
21
GH Research
GHRS
$837M
| – | – |
-185,653
| Closed | -$1.98M |
|